Be the first to like this.
4 comment(s). Last comment by gundamkong 2020-05-06 12:51
Posted by Lalis > 2019-06-27 15:23 | Report Abuse
Looks like a year have already passed here anyway. Thanks in advance for that matter, but how is it really going assuming the whole scums going on in the world with that anti-vaccine things for that ? Does anybody knows that really or not ?
Posted by Tygobar > 2019-10-15 15:29 | Report Abuse
What do you mean by "how" honestly ? I am completely lost with that matter anyway totally and completely. I want some more feedback how that medical company are doing today with all that going on lately with it. I hope you really do.
Posted by gundamkong > 2020-05-06 12:51 | Report Abuse
Dynavax Donates 10,000 Doses of HEPLISAV-B® Vaccine to Emergency Healthcare Providers and Hospital Staff to Protect Against Hepatitis B Infections Amidst COVID-19 Pandemic
GlobeNewswire GlobeNewswire8 April 2020Comment
The U.S. FDA approved vaccine is being provided to help protect critical healthcare workers in emergency medical settings from hepatitis B infections
No result.
1
CEO Morning Brief
US Got the World Driving. Now It’s Going Home — David Fickling
2
CEO Morning Brief
3
CEO Morning Brief
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
4
CEO Morning Brief
Boeing to Lay Off Over 2,500 Workers in US as Part of Sweeping Cuts
5
CEO Morning Brief
#
Stock
Score
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Posted by georgenegrete > 2018-06-28 07:44 | Report Abuse
Dynavax Technologies (DVAX) has formed a six-member Scientific Advisory Board with significant experience in research, development, and commercialization in the fields of oncology and immunology http://crweworld.com/article/news-provided-by-globenewswire/719292/dynavax-appoints-scientific-advisory-board-to-support-its-oncology-and-vaccine-programs